Article citationsMore>>

National Cancer Institute, “Phase III Randomized Study of Cetuximab and/or Bevacizumab in Combination with either Oxaliplatin, Fluorouracil, and Leucovorin Calcium (FOLFOX) or Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium (FOLFIRI) in Patients with Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum,” 2012. http://www.cancer.gov/search/ResultsClinicalTrialsAdvanced.aspx?protocolsearchid=5463125

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top